Date: June 1, 2022Attention: All Providers Effective Date: June 1, 2022Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated with the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.
Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that the Health and Human Services Commission (HHSC) staff continues to revise the Texas Medicaid Provider Procedures Manual (TMPPM) Outpatient Drug Services Handbook.
How this impacts providers: HHSC will remove procedure codes J9219, J9600, and Q0139 from the June 2022 Outpatient Drug Services Handbook. Please refer to the table below for details of the change.
Procedure Code
Affected Subsection
Additional Information
J9219
7.57 “Leuprolide Acetate (Lupron Depot)”
Procedure code is not a benefit. All other procedure codes in this subsection remain a benefit of Medicaid.
J9600
7.7.16 “Porfimer (Photofrin)”
Procedure code is not a benefit
Q0139
7.53 “Iron Injections”
Refer to the Clinics and Other Outpatient Facility Services Handbook, subsection 6.2.2, “Renal Dialysis Facilities-Consolidated Billing,” for information about procedure code Q0139